- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 61.39M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $30.28M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $30.21M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $213.71M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $284.54M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $91.94M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $71.19M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $28.2M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $33.22M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $87.61M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $92.87M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $311.19M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $362.26M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $344.77M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $396.95M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 60.18M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.49M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$30.27M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $437.33M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $473.58M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.78 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.78 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $15.25M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $37.15M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$46.96M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$52.39M |